Web Results


Merck responded by issuing a rebuttal of the Jüni et al. meta-analysis that noted that Jüni omitted several studies that showed no increased cardiovascular risk. ( Merck & Co., 2004). In 2005, advisory panels in both the U.S. and Canada encouraged the return of rofecoxib to the market, stating that rofecoxib's benefits  ...


Parties, docket activity and news coverage of federal case Jean Adams v. Merck Sharp & Dohme Corp., et al, case number 15-56997, from Appellate - 9th Circuit Court. ... Defendant-Appellee. Amylin Pharmaceuticals, Inc. Represented by: Laurendeau,Amy Jean,. Goetz,Richard Blair,. Hacker,Jonathan,. Defendant- Appellee.


Gilead Sciences, Inc. v. Merck & Co, Inc. et al. Plaintiff: Gilead Sciences, Inc. Defendant: Merck & Co, Inc., Merck Sharp and Dohme Corp and Isis Pharmaceuticals, Inc. Case Number: 3:2013cv04057. Filed: August 30, 2013. Court: California Northern District Court. Office: San Francisco Office. County: San Mateo. Presiding ...


Bristol-Myers Squibb Co. et al v. Merck & Co Inc., No. 1:2014cv01131 - Document 213 (D. Del. 2016) case opinion from the District of Delaware US Federal District Court.


Mar 26, 2003 ... Case opinion for CA Court of Appeal FRIEDMAN v. MERCK CO. Read the Court's full decision on FindLaw. ... Jerold Daniel FRIEDMAN, Plaintiff and Appellant, v. MERCK & CO., Inc. et al., Defendants and Respondents. ...... Rptr.2d 663, disapproved on another point in Adams v. Paul (1995) 11 Cal.4th 583, ...


CO INC. Tomas. Abreu. Morelli Ratner PC. ;BCBSFL. 11690-06. NJ. 11690-06 9/ 8/2006 ABREU LUIS VS MERCK & CO. INC. Luis. Abreu. Weitz & Luxemberg. ; NHP; ... NJ. 15379-06 9/28/2006 ADAMS WILLIAM L ET AL VS. MERCK. William. Adams. Weitz & Luxemberg. ;HMSA012909_Raw;TrustMark;Vista;HA;BCBSAssn  ...


Oct 20, 2017 ... Yes. 03/29/17 Current. L -002249-12 Pantaleone Nick Vs Merck And. Co Inc Etal. L -002250-12 Cosentino John Vs Merck And Co. Inc Etal. L -002254-12 Hellman Brett Vs Merck Sharp &. Dohme C. L -002255-12 Grossman Andrew Vs Merck. Sharp & Dome C. Propecia Pro Hac Vice Orders & Compliance.


Novo Nordisk Inc., No. 6:13-cv-01516-LSC (filed Aug. 16, 2013 N.D. Ala.). Judicial Panel on Multidistrict Litigation. Order Consolidating Cases for Purposes of Discovery, Scott v. Merck & Co, Inc., et al., 12cv2549-AJB (S.D. Cal. Feb. 4, 2013). Judicial Panel on Multidistrict Litigation. (2015). Pending MDL Dockets by District.


Merck & Co., Inc. $1,857,395. 9/4/2013, Puerto Rico v. Shell Oil Co., et al. (MTBE Groundwater Contamination) ChevronTexaco Corporation, Exxon Mobil, Royal Dutch Shell PLC, $0. 9/4/2007, Bridge Medical Stockholder Lawsuit AmerisourceBergen, $26,900,000. 9/30/2016, China Subsidiary Bribery Investigation